Wysocki Grzegorz, Czapla Michał, Uchmanowicz Bartosz, Fehler Piotr, Aleksandrowicz Katarzyna, Rypicz Łukasz, Wolska-Zogata Irena, Uchmanowicz Izabella
LUX MED Medical Center, Warsaw, Poland.
Department of Emergency Medical Service, Wroclaw Medical University, Wroclaw, Poland.
Patient Prefer Adherence. 2023 Apr 18;17:1075-1092. doi: 10.2147/PPA.S403437. eCollection 2023.
Ankylosing spondylitis (AS) is a chronic, progressive disease, often with multiple complications, with periods of exacerbation and remission. The onset of the disease usually affects people under 30 years of age. The disease impairs physical, psychological, and social functioning, leading to disability. Therefore, patients with AS face the challenge of adapting to life with the condition and deteriorating quality of life (QoL).
This study aimed to assess the impact of disease acceptance on quality of life in patients with AS.
The study was conducted in the Department of Rheumatology and Internal Diseases of the University Hospital in Wrocław among 110 patients (67 men and 43 women) with the diagnosis of AS, aged 20-89 years (=48.44 years, SD±12.55). The study used the Acceptance of Illness Scale (AIS), the WHOQoL-BREF Quality of Life Scale, and a self-constructed questionnaire of clinical and sociodemographic data.
Respondents rated the quality of life as good and moderate (M = 3.49 points, SD=±0.84). The mean AIS score was 27.44 (SD=±8.67). AIS scores are positively correlated with all QoL domains and perception of quality of life and health (<0.001). The strongest correlation was in the physical domain (=0.71), while the weakest correlation was observed in the social domain (=0.329). AIS and QoL measures showed significant relationships with selected sociodemographic data (eg, gender, age, education, and occupational activity) and correlated with selected disease data (eg, type of treatment used, duration of disease, or comorbidities).
AIS in patients with AS condition correlated positively with their QoL in all domains. Both disease acceptance and quality of life are influenced by specific sociodemographic and disease-related data. Prevention of complications and the type of treatment for AS (primarily biological treatment) can be essential in improving patients' quality of life.
强直性脊柱炎(AS)是一种慢性进行性疾病,常伴有多种并发症,有病情加重和缓解期。该病通常在30岁以下人群中发病。疾病会损害身体、心理和社会功能,导致残疾。因此,强直性脊柱炎患者面临着适应病情和生活质量下降的挑战。
本研究旨在评估疾病接纳度对强直性脊柱炎患者生活质量的影响。
该研究在弗罗茨瓦夫大学医院的风湿病与内科进行,研究对象为110例确诊为强直性脊柱炎的患者(67名男性和43名女性),年龄在20 - 89岁之间(平均年龄 = 48.44岁,标准差±12.55)。研究使用了疾病接纳量表(AIS)、世界卫生组织生活质量简表(WHOQoL - BREF)以及自行编制的临床和社会人口学数据问卷。
受访者对生活质量的评价为良好和中等(M = 3.49分,标准差 = ±0.84)。AIS平均得分为27.44(标准差 = ±8.67)。AIS得分与所有生活质量领域以及生活质量和健康感知呈正相关(<0.001)。最强的相关性出现在身体领域(=0.71),而在社会领域观察到的相关性最弱(=0.329)。AIS和生活质量测量结果与选定的社会人口学数据(如性别、年龄、教育程度和职业活动)显示出显著关系,并与选定的疾病数据(如所用治疗类型、病程或合并症)相关联。
强直性脊柱炎患者的AIS与所有领域的生活质量呈正相关。疾病接纳度和生活质量均受特定社会人口学及疾病相关数据的影响。预防并发症以及强直性脊柱炎的治疗类型(主要是生物治疗)对于改善患者生活质量可能至关重要。